Gold, Silver prices today: Gold, viewed as a hedge against inflation and currency debasement has risen over 25% this year, supported by unprecedented monetary stimulus from major central banks

The outcome of immunogenicity blood tests conducted on a subgroup of older study participants echoed data published in July this year that revealed that the coronavirus vaccine produced robust immune responses in healthy adults aged 18-55 years

Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy

India Stock Market Highlights Today: Reliance Industries, followed by Tata Steel, Bajaj Finance, Asian Paints, M&M, ICICI Bank and Bajaj Finserv were among the top laggards in the Sensex pack today. On the other hand, IndusInd Bank, Nestle India, PowerGrid and L&T were among the gainers

Coronavirus vaccine administered through the intramuscular injection route protects the lower lungs but not the upper lung. Nasal vaccines can protect the lungs completely and stop transmission and also infection

COVID-19 vaccine: The deliberations by the high-level National Expert Vaccine Group on Vaccine Administration comes after Prime Minister Narendra Modi underscored the geographical span of the country

Coronavirus vaccine update: Testing of the AstraZeneca vaccine, developed with Oxford University, has already resumed in the United Kingdom, Brazil, South Africa and Japan

Tedros said too many countries were now seeing an exponential increase in infections, \"and that is now leading to hospitals and intensive care units running close or above capacity -- and we're still only in October\".

Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company

Initially, the cost of the RT-PCR test in the national capital was Rs 4,800. It was later reduced to Rs 2,400. However, in the neighbouring states, such as Haryana, the test cost is half of Delhi. In Haryana, a solo RT-PCR test cost is Rs 1,200, and in Uttar Pradesh, it is Rs 1,600

The funds provisioned, so far are for the current financial year ending March 31, and going further, there will be no shortage of them for this purpose

Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials

COVID-19 vaccine: The US government is \"cautiously optimistic\" that one or two vaccines, likely from Pfizer Inc or Moderna Inc, will be available by the end of the year

AstraZeneca vaccine trials: An AstraZeneca spokesperson, while declining to comment on the volunteer's death, said that there were no concerns that would lead the trials to be paused

Notably, Serum Institute of India is working with AstraZeneca and Oxford University to conduct trials and produce their vaccine candidate once it receives the required regulatory approvals

The Calcutta High Court has eased its order and allowed entry of up to 45 people at a time in a pandal. However, the court upheld its ban on assembly of people inside pandals for rituals like Pushpanjali and Sindoor Khela

India has 29,000 storage points, 83,000 deep freezers, 736 district stores and 258 cold rooms to store vaccines, but they have to be scaled up further for India to vaccinate all its people

Coronavirus vaccine news: Britain will help fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of vaccines against it

Prime Minister Narendra Modi addressed the inaugural function of Grand Challenges Annual Meeting 2020, virtually via video conferencing. PM Modi said that the country was witnessing a decline in the number of coronavirus cases per day and its growth rate. He said that the country is at the forefront of COVID vaccine development and is working on putting a well-established vaccine delivery system in place. Talking about the vaccine industry in India, Modi added that the country is known for its proven capacity to produce quality vaccines and medicines at low cost. Watch the video for more.Also Read: PM Modi Speech Highlights: No leniency till we get a vaccine, says PM

The government is enterprising to ensure that coronavirus vaccine, when it comes, reaches every Indian as soon as possible, said PM Narendra Modi